As Federally Funded Medical Research Decreases in the US, Chinese Biotech Surges 500 Percent

A recent publication by the American Society of Clinical Oncology (ASCO) emphasized the traditional key role of US investment in cancer research. However, they also noted both a 75-percent drop in the number of fully-funded National Institutes of Health (NIH) studies presented at the ASCO Annual Meetings from 2008 to 2017, and a serious drop in the number of new NIH proposals funded—from 27 percent in 2001 to just 12 percent in 2015.